News Sentiment

NBTX sentiment intelligence

Nanobiotix news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 67 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 37.79 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-5.7% over one week, +4.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Nanobiotix Shares Soar Nearly 5%, Targeting Resistance at €36.20

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction -5.7% Price reacting lower
Trend fit Trend active 4.2% over four weeks
Fair value 213.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 44
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Idéal Investisseur 13
TradingView 13
Market source 10
Stock Titan 7
GlobeNewswire 4
MT Newswires 3
Seeking Alpha 2
TradingKey 2

Event Lens

What the news is about

Classified themes
Market update 47
Earnings 13
Analyst action 4
Balance sheet 2
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 67
Idéal Investisseur Direct company coverage

Nanobiotix Shares Soar Nearly 5%, Targeting Resistance at €36.20

Nanobiotix shares gained almost 5%, reaching €32.76, making it one of the strongest performers in the SBF 120. This rebound follows a week of consolidation, pushing the stock closer to its MM20 moving average. The company's annual performance remains exceptionally strong, with a

Tone
Positive 73/100
Event
Market update
Published
21 Jul 2026 09:40
Source
Idéal Investisseur
Idéal Investisseur Direct company coverage

Nanobiotix Shares Soar by 4.5%, Leading the SBF 120

Nanobiotix shares gained 4.25% to €34.36, leading the SBF 120 and moving above its short-term moving averages. The company's annual performance remains strong, driven by clinical advancements of its candidate JNJ-1900 (NBTXR3) and encouraging phase 2 results. The stock's current

Tone
Positive 71/100
Event
Earnings
Published
20 Jul 2026 12:39
Source
Idéal Investisseur
Idéal Investisseur Direct company coverage

Nanobiotix Shares Drop Nearly 3% Yet Maintain an Annual Gain of 692%

Nanobiotix stock experienced a nearly 3% drop on Wednesday, placing it among the biggest declines in the SBF 120 index. This downturn is attributed to profit-taking following strong gains, despite the company still boasting an impressive annual performance of nearly 692%. The sto

Tone
Positive 66/100
Event
Market update
Published
15 Jul 2026 12:15
Source
Idéal Investisseur
TradingView Direct company coverage

Price to sales forward of Nanobiotix SA – EURONEXT:NANO

The article provides a financial overview of Nanobiotix SA (EURONEXT: NANO), specifically focusing on its forward price-to-sales ratio. It indicates that the market is closed, and there are no current trades for the stock, with the content being a snapshot from TradingView's fina

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 00:12
Source
TradingView
TradingView Direct company coverage

Nanobiotix S.A. Stock 12‑Month Price Target Raised to $54.34, Implies 40% Upside

Nanobiotix S.A. (NANO) has seen its average 12-month price target raised to $54.34 by 8 analysts, up from $52.3, suggesting a 40% potential upside from its Jul. 9 closing price. The consensus rating among 9 analysts remains a "Buy," with 8 recommending Buy and 1 recommending Hold

Tone
Neutral 50/100
Event
Analyst action
Published
10 Jul 2026 13:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Nanobiotix SA – EURONEXT:NANO

The article provides financial information for Nanobiotix SA (Euronext: NANO), specifically focusing on its enterprise value to EBIT forward. It indicates basic financial data for the company on the TradingView platform, noting that the market was closed at the time of publicatio

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 09:40
Source
TradingView
Idéal Investisseur Direct company coverage

Nanobiotix Shares Soar Over 5%, Landing on the SBF 120 Podium

Nanobiotix shares surged over 5% in early trading, propelled by a "buy" rating and a €56 target price from Portzamparc, representing a potential upside of over 55%. The biotech stock broke through its resistance at €35.18, signaling a bullish resumption, and has seen a 668% gain

Tone
Positive 74/100
Event
Analyst action
Published
10 Jul 2026 09:39
Source
Idéal Investisseur
TradingView Direct company coverage

Price to sales forward of Nanobiotix SA – MUN:5NR

This article provides financial information for Nanobiotix SA (MUN:5NR), specifically focusing on its price-to-sales forward metric. It appears to be a stub or a data point from a financial platform like TradingView, with no further detailed analysis provided. The content highlig

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 03:39
Source
TradingView
Idéal Investisseur Direct company coverage

Nanobiotix Shares Confirm Their Rebound with a +625% Yearly Increase

Nanobiotix shares have confirmed their rebound, showing a +625% increase over the past year. The French biotech company's stock is up 2.03% to €34.10, trading above its short-term moving averages and indicating continued bullish momentum with an RSI of 57. This growth is supporte

Tone
Positive 95/100
Event
Market update
Published
09 Jul 2026 15:11
Source
Idéal Investisseur
Stock Titan Direct company coverage

If You Invested $1,000 in Nanobiotix S.A. (NBTX)

This article examines the historical performance of Nanobiotix S.A. (NBTX) stock, illustrating how a $1,000 investment would have grown over various periods. It details the company's focus on physics-based therapeutic approaches, particularly its oncology product candidate JNJ-19

Tone
Positive 65/100
Event
Market update
Published
04 Jul 2026 05:09
Source
Stock Titan
Finviz Direct company coverage

NBTX - Nanobiotix ADR Dividends

This article provides detailed financial data and performance metrics for Nanobiotix ADR (NBTX). It covers key financial figures such as market cap, income, sales, and various ratios, along with stock performance over different periods. The data indicates strong past performance

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 01:39
Source
Finviz
Idéal Investisseur Direct company coverage

Nanobiotix Shares Soar 5% and Aim for Record Highs

Nanobiotix shares have surged by 5% and are targeting new record highs, becoming a top performer on the Paris index after a period of consolidation. The company's strong performance is supported by technical indicators, significant advances in clinical studies for JNJ-1900, the s

Tone
Positive 73/100
Event
Market update
Published
03 Jul 2026 17:43
Source
Idéal Investisseur
Idéal Investisseur Direct company coverage

Nanobiotix Shares Up 3.73%, Targeting the 50-Day Moving Average of €32.70

Nanobiotix shares have risen by 3.73% to €32.28, nearing their 50-day moving average of €32.70. This rebound follows a period of consolidation after an annual rally, positioning the stock among the top performers on the SBF 120. Despite a recent increase in bearish pressure, the

Tone
Positive 66/100
Event
Market update
Published
30 Jun 2026 10:10
Source
Idéal Investisseur
Idéal Investisseur Direct company coverage

Nanobiotix Shares Decline by 1.5% and Remain Under Pressure Following May Record

Nanobiotix shares have fallen by 1.5% and continue to face pressure in a declining Parisian market, consolidating after hitting a record high in mid-May. The stock is currently trading near its 20-day moving average, with bearish bets increasing, although the total short position

Tone
Negative 39/100
Event
Market update
Published
29 Jun 2026 12:41
Source
Idéal Investisseur
TradingView Direct company coverage

Enterprise value to EBITDA forward of Nanobiotix SA – EURONEXT:NANO

This article provides access to the enterprise value to EBITDA forward for Nanobiotix SA (EURONEXT:NANO). It primarily functions as a financial data page on TradingView, indicating that specific financial metrics for the company are available for users to view. The content points

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 14:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Nanobiotix SA – AQUISEU:NANOP

This article provides financial data for Nanobiotix SA (NANOP), specifically its enterprise value to EBITDA forward. It details that the market for this stock is currently closed with no trades recorded. The information is presented by TradingView, sourcing data from ICE Data Ser

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 08:39
Source
TradingView
TradingView Direct company coverage

NANO Forecast — Price Target — Prediction for 2027

This article provides an in-depth analysis of Nanobiotix SA (NANO) stock, including its current price, analyst forecasts, historical performance, and financial data. It highlights the company's recent stock increase over the last year, future earnings and revenue expectations, an

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 01:06
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Nanobiotix SA – EURONEXT:NANO

The article focuses on financial data for Nanobiotix SA (NANO) on Euronext, specifically its "Price to earnings forward" metric. It appears to be a financial data page from TradingView, providing an overview of the company's financial performance, news, and community discussions.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 01:05
Source
TradingView
TradingView Direct company coverage

NBTX Forecast — Price Target — Prediction for 2027

This article provides a price target and analyst ratings for Nanobiotix S.A. (NBTX) for 2027. Nine analysts offer a 1-year price forecast with an average target of 49.59, though maximum and minimum estimates are not provided. The content also notes that 10 analysts have given sto

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 21:10
Source
TradingView
TradingView Direct company coverage

Price to book forward of Nanobiotix SA – EURONEXT:NANO

This article displays the "Price to book forward" financial metric for Nanobiotix SA (Euronext: NANO) as found on TradingView. It indicates that no trades were recorded and the market was closed at the time of access. The data is provided by ICE Data Services and FactSet, with SE

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 11:10
Source
TradingView
Idéal Investisseur Direct company coverage

Nanobiotix Shares Fall by 2.5%, in the Red on the SBF 120

Nanobiotix shares have fallen by 2.5% on the SBF 120, extending a consolidation phase due to renewed risk aversion from U.S. inflation figures. Despite a monthly decline of over 20%, the stock's annual performance remains strong, boasting over 640% growth. The biotech is also aff

Tone
Negative 30/100
Event
Macro sensitivity
Published
26 Jun 2026 10:38
Source
Idéal Investisseur
TradingView Direct company coverage

Nanobiotix SA Actuals & Estimates (EURONEXT:NANO)

This article provides an overview of Nanobiotix SA (NANO) stock, including its current price, performance trends, and analyst forecasts. It details financial actuals and estimates for income, balance sheet, and cash flow, alongside key metrics like market capitalization, EBITDA,

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 18:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of Nanobiotix SA – GETTEX:5NR

This article provides financial information for Nanobiotix SA (GETTEX:5NR), specifically focusing on its price to book forward metric. It appears to be a financial data snippet from TradingView, offering a quick look at the company's valuation under the "Financials" section. The

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 15:09
Source
TradingView
Idéal Investisseur Direct company coverage

Nanobiotix Shares Fall by 2.5%, Down Nearly 19% Over the Month

Nanobiotix shares have fallen by 2.5% today and nearly 19% over the past month, trading at €29.50. This decline occurs despite a positive trend in the broader Parisian market and successful progress in the company's clinical trials and cash reserve reinforcement. The stock's perf

Tone
Negative 28/100
Event
Balance sheet
Published
25 Jun 2026 09:40
Source
Idéal Investisseur
TradingView Direct company coverage

Price to sales forward of Nanobiotix SA – GETTEX:5NR

This article displays the "Price to sales forward" financial metric for Nanobiotix SA, traded on Gettex under the symbol 5NR. The content primarily shows the financial data with a period, value, change, and change percentage. There is no additional textual analysis or commentary

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 08:40
Source
TradingView
TradingKey Direct company coverage

Nanobiotix SA (NBTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nanobiotix SA (NBTX), detailing its current stock price, market capitalization, and various technical indicators. It presents a summary of buy, neutral, and sell signals derived from indicators like MACD, RSI, and moving averages, and

Tone
Negative 31/100
Event
Market update
Published
24 Jun 2026 12:39
Source
TradingKey